GC Temp PRINT
Biocompatible Class IIa 3D printing resin for temporary dental crowns and bridges, optimized for DLP-based printers with exceptional mechanical stability and long-term storage performance
- CEO / Founder
- Yutaka Suzuki
- Team Size
- 1001-5000
- Stage
- Active
Technology & Products
Key Products
GC Temp PRINT resin (500g medium viscosity); COE-SOFT™ PRINT denture material
Technological Advantage
Patented filler technology achieves 99%+ accuracy in temporary restorations with 40% faster print cycles vs conventional dental resins; FDA-cleared Class IIa biocompatibility enables clinical use without MMA toxicity risks
Differentiation
Value Proposition
Enables precise, on-demand production of temporary dental restorations with 180-day durability, eliminating methyl methacrylate (MMA) for improved biocompatibility and reducing traditional lab turnaround from weeks to hours
How They Differentiate
3x longer shelf stability (24+ months) vs KeyPrint's 12 months; 25% higher fracture resistance than Lucitone resins; Zero MMA content vs competitors' 5-15% MMA formulations
Market & Competition
Target Customers
Dental professionals, dental labs, prosthodontists
Industry Verticals
Dental; Medical Devices
Competitors
KeyPrint® (Keystone Industries); Lucitone Digital Print System (Dentsply Sirona); Formlabs Dental Resins
Growth & Milestones
Growth Metrics
GC America holds 15% global market share in dental consumables; Dental 3D printing materials segment growing 40% YoY
Major Milestones
1992: Founded as U.S. subsidiary of GC Corporation; 2014: Won Deming Prize for quality management; 2023: Launched COE-SOFT™ PRINT with Aspen Dental; 2024: GC Holding AG appointed new CEO
Notable Customers
Aspen Dental clinics; Straumann-affiliated dental practices; Henry Schein Zahn partner labs